Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-05

Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Multiple Sclerosis

View source ↗

Summary

A pilot study investigating the role of gut flora in Multiple Sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ProgenaBiome | Conditions: Multiple Sclerosis, MS | Status: WITHDRAWN